A New Oral Treatment For Type II Diabetes Mellitus
NCT00111800
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
375
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG:
Placebo
DRUG:
DEN 2.5 mg
DRUG:
DEN 7.5 mg
DRUG:
DEN 15 mg
DRUG:
DEN 30 mg
DRUG:
DEN 45 mg
Sponsor
GlaxoSmithKline